Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05265806Completed
Randomised, double-blind trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) (3 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: fNIRS based measures of touch processing and Ratings of pleasantness, arousal, intensity and payment. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05265806.